Orchestra BioMed’s BackBeat Cardiac Neuromodulation Therapy Gets CE Mark for Hypertension Treatment

BackBeat CNT CE mark
Image: Orchestra Biomed
Orchestra BioMed, a Pennsylvania-based biomedical innovation company received CE Mark approval for its Moderato implantable pulse generator system that delivers BackBeat Cardiac Neuromodulation Therapy (CNT) for treatment of hypertension while […]
To access this page, watch the live streams and videos on-demand, please register free of charge to the WT | Wearable Technologies COMMUNITY.
Previous articleVivaLNK Partners with Emory University to Provide Wearable ECG Sensors for Study
Next articleAlphabet and iRhythm Partner Up to Develop Health Management Solutions for Atrial Fibrillation Patients
Sam Draper () is Online Editor at WT | Wearable Technologies specialized in the field of sports and fitness but also passionated about any new lifestyle gadget on the market. Sam can be contacted at press(at)wearable-technologies.com.